These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Recommendations on the drug treatment of psychosis in Parkinson's disease. Friedman JH Am J Med; 2010 Apr; 123(4):e19; author reply e21. PubMed ID: 20362738 [No Abstract] [Full Text] [Related]
5. Drugs to treat dementia and psychosis: management of Parkinson's disease. Mov Disord; 2002; 17 Suppl 4():S120-7. PubMed ID: 12211152 [No Abstract] [Full Text] [Related]
6. The management of psychosis in movement disorder patients. Chou KL; Borek LL; Friedman JH Expert Opin Pharmacother; 2007 May; 8(7):935-43. PubMed ID: 17472539 [TBL] [Abstract][Full Text] [Related]
7. Use of risperidone in psychosis associated with Huntington's disease. Madhusoodanan S; Brenner R Am J Geriatr Psychiatry; 1998; 6(4):347-9. PubMed ID: 9793585 [No Abstract] [Full Text] [Related]
8. Treatment with risperidone of an acute psychotic episode in a patient with AIDS. Zilikis N; Nimatoudis I; Kiosses V; Ierodiakonou C Gen Hosp Psychiatry; 1998 Nov; 20(6):384-5. PubMed ID: 9854654 [No Abstract] [Full Text] [Related]
11. The response of psychotic symptoms in a patient with resistant schizophrenia under treatment of high-dose risperidone long-acting injection. Hou YC; Lai CH J Neuropsychiatry Clin Neurosci; 2014; 26(3):E16-7. PubMed ID: 25093771 [No Abstract] [Full Text] [Related]
13. Safety and efficacy of risperidone in substance abusers with psychosis. Albanese MJ Am J Addict; 2001; 10(2):190-1. PubMed ID: 11444160 [No Abstract] [Full Text] [Related]
14. Duration of risperidone treatment for BPSD. Snowdon J; Brodaty H; Ames D; Day S Int J Geriatr Psychiatry; 2006 Jul; 21(7):699-701. PubMed ID: 16821255 [No Abstract] [Full Text] [Related]
15. Risperidone treatment for psychosis in end-stage Friedreich's ataxia. Salbenblatt MJ; Buzan RD; Dubovsky SL Am J Psychiatry; 2000 Feb; 157(2):303. PubMed ID: 10671420 [No Abstract] [Full Text] [Related]
16. Clozapine-induced aplastic anemia in a patient with Parkinson's disease. Ziegenbein M; Steinbrecher A; Garlipp P Can J Psychiatry; 2003 Jun; 48(5):352. PubMed ID: 12866349 [No Abstract] [Full Text] [Related]
17. Clozapine for the treatment of psychosis in Parkinson's disease: chart review of 49 patients. Wagner ML; Defilippi JL; Menza MA; Sage JI J Neuropsychiatry Clin Neurosci; 1996; 8(3):276-80. PubMed ID: 8854298 [TBL] [Abstract][Full Text] [Related]
18. Update on the Management of Parkinson's Disease: Focus on Psychosis. Brandt NJ; Chen JJ; Menza M Consult Pharm; 2016; 31(9 Suppl 1):1-16. PubMed ID: 27629061 [No Abstract] [Full Text] [Related]
19. Risperidone in Parkinson's disease. Ford B; Lynch T; Greene P Lancet; 1994 Sep; 344(8923):681. PubMed ID: 7520964 [No Abstract] [Full Text] [Related]
20. The use of risperidone for psychosis and agitation in demented patients with Parkinson's disease. Workman RH; Orengo CA; Bakey AA; Molinari VA; Kunik ME J Neuropsychiatry Clin Neurosci; 1997; 9(4):594-7. PubMed ID: 9447503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]